Diabetes Smoking Cessation Incentives Study
CRUK2
Incentives to Promote Smoking Cessation for Individuals With Diabetes
1 other identifier
interventional
29
1 country
1
Brief Summary
The purpose of this study is to evaluate the feasibility of contingency management on improving smoking cessation among individuals with type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2020
CompletedFirst Posted
Study publicly available on registry
December 23, 2020
CompletedStudy Start
First participant enrolled
January 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 7, 2022
CompletedMay 26, 2022
May 1, 2022
1.2 years
December 18, 2020
May 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of participants completing 6 study visits
Feasibility outcome: completion of 6 study visits
5 weeks
Number of participants with >80% completion of daily ecological momentary assessments (EMA) completed
Feasibility outcome: completion of EMA portion of study
4 weeks
Secondary Outcomes (1)
Number of participants with biochemically verified abstinence at 4 weeks post quit
5 weeks
Study Arms (2)
Contingency Management
EXPERIMENTALParticipants in the contingency management (CM) treatment arm will receive the usual care (UC) treatment program offered at the Tobacco Treatment Research Program (TTRP) and will be eligible to earn gift cards at each weekly visit on their quit date up until four weeks post-quit for proof of abstinence. They will earn $20 in gift cards for quitting on the specified quit day (i.e., one week after the orientation visit), and this amount will increase by $5 with each successive weekly abstinent visit (i.e., up to $40 in gift cards at 4 weeks post-quit; up to $150 total).
Usual Care
PLACEBO COMPARATORParticipants in the usual care (UC) group will receive the standard smoking cessation treatment offered at the Health Promotion Research Center's Tobacco Treatment Research Program (TTRP) at the University of Oklahoma. This includes at least 4 treatment sessions of counseling and the opportunity to use nicotine replacement therapy or medications.
Interventions
Escalating financial incentives contingent upon biochemical evidence of abstinence
Usual care smoking cessation support
Eligibility Criteria
You may qualify if:
- Diagnosed with type 2 diabetes
- earn a score \> 4 on REALM indicating \> 6th grade English literacy level
- willing to quit smoking 7 days from their first visit
- have an expired CO level \>8 ppm suggestive of current smoking at baseline
- currently smoking \> 5 cigarettes per day
- willing and able to attend 6 study visits
You may not qualify if:
- unable to demonstrate use of or unwilling to use the remote CO monitor and phone app
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oklahoma Tobacco Research Center
Oklahoma City, Oklahoma, 73104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sydney Martinez, PhD
University of Oklahoma
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2020
First Posted
December 23, 2020
Study Start
January 8, 2021
Primary Completion
April 7, 2022
Study Completion
April 7, 2022
Last Updated
May 26, 2022
Record last verified: 2022-05